Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 13, Number 11—November 2007

Research

Protection and Virus Shedding of Falcons Vaccinated against Highly Pathogenic Avian Influenza A Virus (H5N1)

Michael Lierz*Comments to Author , Hafez M. Hafez*, Robert Klopfleisch†, Dörte Lüschow*, Christine Prusas*, Jens P. Teifke†, Miriam Rudolf†, Christian Grund†, Donata Kalthoff†, Thomas Mettenleiter†, Martin Beer†, and Timm Harder†
Author affiliations: *Freie Universität, Berlin, Germany; †Federal Research Institute for Animal Health, Greifswald-Insel Riems, Germany;

Main Article

Figure 1

Titers (log2) of hemagglutination-inhibiting antibodies of 5 vaccinated Gyr-Saker hybrid falcons before and 11 days after challenge with 106.0 50% egg infectious doses of the highly pathogenic avian influenza strain A/Cygnus cygnus/Germany/R65/06 (H5N1), tested against antigen of the challenge virus and the low pathogenicity avian influenza vaccine strain A/duck/Potsdam/1402/86 (H5N2). Open circle, individual outlier.

Figure 1. Titers (log2) of hemagglutination-inhibiting antibodies of 5 vaccinated Gyr-Saker hybrid falcons before and 11 days after challenge with 106.0 50% egg infectious doses of the highly pathogenic avian influenza strain A/Cygnus cygnus/Germany/R65/06 (H5N1), tested against antigen of the challenge virus and the low pathogenicity avian influenza vaccine strain A/duck/Potsdam/1402/86 (H5N2). Open circle, individual outlier.

Main Article

TOP